Stockreport

CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highlights: Navigating Revenue ... [Yahoo! Finance]

CollPlant Biotechnologies Ltd. - Ordinary Shares  (CLGN) 
US:NASDAQ Investor Relations: collplant.com/investor-relation
PDF Q4 2024 Cost of Revenue: $272,000, down from $773,000 in Q4 2023. Full Year 2024 Cost of Revenue: $1.6 million, down from $2 million in 2023. Q4 2024 Gross Loss: $1 [Read more]